Penn Medicine Provider
Hematology
Daria V. Babushok, MD, PHD
5.0
(114)
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 4th Floor West

About me

  • Assistant Professor of Medicine (Hematology-Oncology)
  • Assistant Professor of Medicine in Pediatrics

Education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: Massachusetts General Hospital
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
5.0

114 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
very professional
May 2025
5.0
5.0
knowledgeable and experienced
May 2025
5.0
5.0
dr. babushok is always friendly and explains everything very thoroughly that i don't feel overwhelmed talking with her. she's also very thorough and pays attention to any details regarding my treatment plan.
April 2025
5.0
5.0
her expertise and office manner is excellent.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Babushok is a Penn Medicine physician.

Qualifications and experience

My research

Sande, CM, Chen, S, Mitchell, DV, Lin, P, Deolikar, RJ, Freeman, C, Zhou, M, Kumar, S, Zheng, S, Munkhbileg, B, Stanley, NL, Guo, K, Hausler, R, Taylor, DM, Corines, J, Morrissette, JJ, Lieberman, DB, Yang, G, Smith-Simmer, K, Banaszak, LG, Shoger, K, Nicholas, P, Walne, AJ, Dokal, I, Rosenheck, J, Churpek, JE, Johnson, FB, Olson, TS, Babushok, DV. The Landscape of Clonal Hematopoiesis in Pediatric and Adult Telomere Biology Disorders , Oral presentation at the 2024 Team Telomere Scientific Summit, Worley, ID.: 2024


Babushok DV, DeZern AE, de Castro CM, Rogers ZR, Beenhouwer D, Broder MS, Fanning SR, Gibbs SN, Hanna R, Maciejewski JP, Scott BL, Tantravahi SK, Wlodarski MW, Yermilov I, Patel BJ. Modified Delphi panel consensus recommendations for management of severe aplastic anemia. , Blood Adv.: 2024


Connor MP, Prathapa N, Frey NV, Gill SI, Hexner EO, Bruno XJ, Lai CE, Loren AW, Luger SM, Matthews AH, McCurdy SR, Perl AE, Porter DL, Zeringue A, Oved JH, Olson TS, Pratz KW, Babushok DV. Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia , Haematologica: 2024


Sung AD, Koll T, Gier SH, Racioppi A, White G, Lew M, Free M, Agarwal P, Bohannon LM, Johnson EJ, Selvan B, Babushok DV, Frey NV, Gill SI, Hexner EO, Martin M, Perl AE, Pratz KW, Luger SM, Chao NJ, Fisher AL, Stadtmauer EA, Porter DL, Loren AW, Bhatt VR, Gimotty PA, McCurdy SR. Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients. , Transplant Cell Ther. : 2024


Zhu, D, Babushok, DV, Patel, NB, Bermudez, CA, Crespo, M, Courtwright, AM. Evaluation of a Screening Protocol for Telomere Biology Disorders in Patients Referred for Lung Transplant. , Poster presentation at the ISHLT 44th Annual Meeting and Scientific Sessions Prague Congress Centre Prague, Czech Republic.: 2024


Chippendale L, Freyer CW, Carulli A, Babushok DV, Frey NV, Gill SI, Hexner EO, Luger SM, Martin ME, Porter DL, Stadtmauer EA, Loren AW. One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant. , J Oncol Pharm Pract. : 2024


Babushok DV, Sabatino DE. Promise of gene therapy for congenital neurologic disease due to GPI deficiency. Promise of gene therapy for congenital neurologic disease due to GPI deficiency. , Mol Ther Methods Clin Dev. : 2024


Hyperactive Notch Signaling as a Potential Mechanism of PIGA–HSPC Clonal Expansion in Immune Bone Marrow Injury. Hyperactive Notch Signaling as a Potential Mechanism of PIGA–HSPC Clonal Expansion in Immune Bone Marrow Injury. , 2024 Gordon Research Seminar on Notch Signaling in Development, Regeneration and Disease, Bates College, Lewiston, Maine, USA.: 2024


Matthew P Connor, MD, Neeharika Prathapa, MBBS, Noelle V. Frey, MD, MS, Saar Gill, MD, PhD, Elizabeth O Hexner, MD, MSTR, Ximena Jordan Bruno, MD1, Catherine Lai, MD, Alison W Loren, MD, Selina M Luger, MD, FRCPC, Andrew H Matthews, MD, Shannon R McCurdy, MD, Alexander Perl, David L. Porter, MD, Arlene Zeringue, Joseph H. Oved, MD, Timothy S Olson, MD, PhD, Keith W Pratz, MD and Daria V Babushok, MD, PhD Hypomethylating Agents Are Associated with High Rates of Hematologic Toxicity in Patients with Secondary MDS/AML That Develops after Acquired Aplastic Anemia , 65th ASH Annual Meeting & Exposition, Poster Presentation, San Diego, CA: 2023


Christopher M. Sande, MD, Stone Chen, Dana V Mitchell, PhD, Ping Lin, Rujul Jagdish Deolikar, Colby Freeman, Mary Zhou, Sushant Kumar, PhD, Shannon Zheng, Bolormaa Munkhbileg, MD, MMS, Natasha L Stanley, DO, Kathy Guo, Ryan Hausler, MS, Deanne M Taylor, PhD, James Corines, DO, Jennifer JD Morrissette, PhD, David B Lieberman, Guang Yang, MD, PhD, Kelcy Smith-Simmer, MMSc, CGC, Lauren G Banaszak, MD, Kyle Shoger, Peter Nicholas, Amanda J Walne, PhD, Inderjeet Dokal, MD, Justin Rosenheck, DO, Jane E Churpek, MD, MS, F Bradley Johnson, MD, PhD, Timothy S Olson, MD, PhD and Daria V Babushok, MD, PhD DNA Damage Response Constrains Cell Growth and Drives Clonal Hematopoiesis in Telomere Biology Disorders , 65th ASH Annual Meeting & Exposition, Poster Presentation, San Diego, CA: 2023


View all publications